Education 2007 – 2013 Medical School, Budapest, Mannheim & Lübeck, Medical State Examination, MD (Germany) 2013 – 2018 Resident Physician, Department of Surgery, Campus Lübeck, University Hospital Schleswig-Holstein (Germany) 2018 – present Resident Physician, Department of Psychiatry and Psychotherapy, Campus Lübeck, University Hospital Schleswig-Holstein (Germany)
Professional Experience 2013 Approbation, Lübeck (Germany) 2013 – 2018 Department of Surgery, University of Lübeck (Germany) 2019 – 2021 Registered Therapist for Metacognitive Therapy (MCT, Level 1 diploma; Germany) 2022 MD Thesis, Department of Surgery, University of Lübeck (Germany)
Helena Rogg’s research focus includes the investigation of the therapeutic potential of psychedelic drugs, especially ketamine, in affective disorders, borderline personality disorder, and suicidality as well as the potential utility of LSD and MDMA for the treatment of mental disorders.
Keywords: psychedelics, interventional psychiatry, deep brain stimulation, OCD
Avram M., Müller F., Rogg H., Korda A., Andreou C. et al. (2022). Characterizing thalamocortical (dys)connectivity following d-amphetamine, LSD, and MDMA administration. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, doi: 10.1016/j.bpsc.2022.04.003
Avram M., Rogg H., Korda A., Andreou C., Müller F., & Borgwardt S. (2021). Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States. Frontiers in Psychiatry, 12, 706017. doi: 10.3389/fpsyt.2021.706017
Best Case Award, “Venostoma – a new approach / access to the venous system? A case report”, Northwest Germany Surgery Conference (NDCH), 2012, Hamburg (Germany)